Participate in Field Testing of Cost Measures Now through September 18
Field testing will take place starting August 17 at 10 a.m. Eastern Time (ET) to September 18, 2020. Clinicians and clinician groups who meet the attribution requirements for at least one of the measures listed below will receive a Field Test Report. All stakeholders are invited to provide feedback on the draft measure specifications through an online survey, which closes on September 18, 2020 at 11:59 p.m. Eastern Time (ET). Participation is voluntary.
The following cost measures are being field tested:
- Asthma/Chronic Obstructive Pulmonary Disease (COPD)
- Colon and Rectal Resection
- Diabetes
- Melanoma Resection
- Sepsis
Access Field Test Reports!
You or your clinician group can download your Field Test Report(s) via the Quality Payment Program website if you or your clinician group meet the minimum number of episodes outlined below:
- 10 episodes for procedural and acute inpatient medical condition cost measures
- 20 episodes for chronic condition cost measures
Field Test Reports contain information about your cost performance. This information will be for field testing purposes only. The measurement period for these Field Test Reports is January 1 to December 31, 2019. Please refer to the Field Test Report Access User Guide for guidance on accessing your Field Test Report.
The draft measure specifications are available on the MACRA Feedback Page.
You may provide feedback through this online survey by 11:59 p.m. ET on September 18, 2020. A document containing specific questions about the measures for stakeholders to reference while reviewing the materials is available on the MACRA Feedback Page.
Learn more about field testing through the Wave 3 Cost Measures Field Testing Webinar
A recording of the Wave 3 Cost Measures Field Testing Webinar is available on the Quality Payment Program Webinar Library. The goal of this webinar recording is to provide detailed information about the measure development process and field testing activities.
No hay comentarios:
Publicar un comentario